NCT01161927View on ClinicalTrials.gov

Bioequivalence Study of Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories Limited Under Non- Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions
Healthy
Interventions
DRUG

Nizatidine

Nizatidine Capsules 300 mg of Dr.Reddy's Laboratories Limited

DRUG

Axid

Axid 300 mg Capsules of Reliant Pharmaceuticals, US

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY